Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
C.BIOV
Alternate Symbol(s):
BVAXF
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(10)
•••
TheWeakendz
X
View Profile
View Bullboard History
Post by
TheWeakendz
on Jun 29, 2021 10:11am
Looking for 0.16, then 0.09???
Eom. Lol. Jmo
(66)
•••
ChaseAckland
X
View Profile
View Bullboard History
Comment by
ChaseAckland
on Jun 29, 2021 9:35am
RE:RE:BioVaxys Is Now On FDA Official SRO List
I beleive it means that the FDA is actively reviewing something..the list is a way for FDA to make sure that there is no internal conflict of interest, i.e. FDA people holding shares of the company
...more
(10)
•••
TheWeakendz
X
View Profile
View Bullboard History
Post by
TheWeakendz
on Jun 28, 2021 11:21pm
Still a small float???
Low teens coming???? Short position went up a week ago(X5, according to ceo.ca). Lol.
(4)
•••
SnowBall123
X
View Profile
View Bullboard History
Comment by
SnowBall123
on Jun 28, 2021 5:56pm
RE:BioVaxys Is Now On FDA Official SRO List
what does it mean to be on SRO list?
(1)
•••
JayMark
X
View Profile
View Bullboard History
Post by
JayMark
on Jun 28, 2021 3:52pm
BioVaxys Is Now On FDA Official SRO List
https://www.fda.gov/about-fda/ethics/listing-significantly-regulated-organizations-sro
(66)
•••
ChaseAckland
X
View Profile
View Bullboard History
Post by
ChaseAckland
on Jun 24, 2021 12:35pm
BIOV Canadian Interview
Biovaxys (BIOV.CSE) CEO James Passin talks about their tech, Covid & cancer treatment during interview with Canadian talk show. https://www.youtube.com/watch?v=K_GRLIZjvzk
(10)
•••
TheWeakendz
X
View Profile
View Bullboard History
Post by
TheWeakendz
on Jun 21, 2021 6:17pm
Ceo.ca showing shorts up 5X
??? Not sure.
(10)
•••
TheWeakendz
X
View Profile
View Bullboard History
Post by
TheWeakendz
on Jun 19, 2021 8:57am
Can we expect any pitfalls???
Eom.
(66)
•••
ChaseAckland
X
View Profile
View Bullboard History
Comment by
ChaseAckland
on Jun 18, 2021 2:18pm
RE:RE:RE:RE:BIOV Papilocare
Sorry! "Papilocare+" is my speculation on overall strategy. If they get FDA approval as a device (which is likely, as its approved in EU as a device) they can market it w/o
...more
(4)
•••
SnowBall123
X
View Profile
View Bullboard History
Comment by
SnowBall123
on Jun 17, 2021 6:33pm
RE:RE:RE:BIOV Papilocare
Yes we all aware of that, the Papilocare, what about the "Papilocare+" ?
(66)
•••
ChaseAckland
X
View Profile
View Bullboard History
Comment by
ChaseAckland
on Jun 17, 2021 6:08pm
RE:RE:BIOV Papilocare
Earlier this year BIO entered a partnership with Procare, a pharmaco in Spain, to codevelop and market BIOV's ovarianc cancer vaccine. The deal included BIOV having right of refusal to
...more
(4)
•••
SnowBall123
X
View Profile
View Bullboard History
Comment by
SnowBall123
on Jun 17, 2021 12:52pm
RE:BIOV Papilocare
Didn't know the "Papilocare+" part, where did it mention?
(66)
•••
ChaseAckland
X
View Profile
View Bullboard History
Post by
ChaseAckland
on Jun 17, 2021 10:52am
BIOV Papilocare
Been taking a look at the numbers for BIOV and Papilocare potenital. Reading from prior PR's they are looking to get FDA approval as a device hopefully this year (same as in the EU, where it
...more
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jun 15, 2021 9:35pm
Biovaxys technology
https://www.youtube.com/watch?v=zEgH4WP5b2c
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Small-Cap Gold Stock Jumped Almost 50% on Friday
Nanalysis Scientific Corp. Announces First Quarter 2024 Results